PIK3CA and neoplasm: The efficacy of alpelisib in reducing tumor volume was slightly improved (not statistically significant) when alpelisib was combined with metformin and dapagliflozin in ER+/PIK3CA mutant HBRX3077 PDX tumor-bearing nude rats.